K
Ka Shing Cheung
Researcher at University of Hong Kong
Publications - 112
Citations - 3769
Ka Shing Cheung is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 65 publications receiving 2319 citations.
Papers
More filters
Journal ArticleDOI
Risk of gastric cancer development after eradication of Helicobacter pylori.
Ka Shing Cheung,Wai K. Leung +1 more
TL;DR: It is necessary to identify patients at high-risk for gastric cancer after H. pylori eradication to streamline the management plan, and identifying medications that could potentially modify the GC risk would be desirable.
Journal ArticleDOI
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation.
Wai-Kay Seto,Kevin Sh Liu,Lung-Yi Mak,Gavin Cloherty,Danny Ka-Ho Wong,Jeffrey Gersch,Yuk-Fai Lam,Ka Shing Cheung,Ning Chow,Kwan-Lung Ko,Wai-Pan To,James Fung,Man-Fung Yuen +12 more
TL;DR: Serum HBV RNA measurement is essential for deciding on entecavir cessation in patients with chronic HBV, especially with low HBsAg levels, and patients can be stratified on their risk of off-treatment relapse based on both viral determinants.
Journal ArticleDOI
Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance.
James Fung,Ka Shing Cheung,Danny Ka-Ho Wong,Lung-Yi Mak,Wai-Pan To,Wai-Kay Seto,Ching-Lung Lai,Man-Fung Yuen +7 more
TL;DR: Male sex, older age at ESC, ALT, and higher level of HBV DNA were associated with higher rates of HCC after ESC, and predictive scores can determine the likelihood of developing HCC and achieving HBsAg seroclearance.
Journal ArticleDOI
Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015.
TL;DR: There is a considerable increase in the incidence and prevalence of primary biliary cholangitis in the Chinese population over the past 16 years, with significant morbidity and mortality.
Journal ArticleDOI
Hepatocellular carcinoma: recent advances and emerging medical therapies.
TL;DR: Recent advances in intra-arterial therapy, multi-kinase inhibitors, and immunotherapy will be reviewed, especially in medical therapies for advanced disease.